The pathophysiology of T2DM is characterized by a decrease in insulin-regulated glucose metabolism (i.e., insulin resistance) accompanied by a decrease (or relative decrease) in insulin secretion due to defective islet b-cell function [3]. Here, INS is linked to Insulin resistance.